Retinal Diseases - A Wheel of Knowledge Challenge!
This activity is supported by independent educational grants from Apellis Pharmaceuticals, Inc.; Astellas; Eyepoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Oculis; Regeneron Pharmaceuticals, Inc.; and Topcon Healthcare, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by independent educational grants from Apellis Pharmaceuticals, Inc.; Astellas; Eyepoint Pharmaceuticals, Inc.; Genentech, a member of the Roche Group; Oculis; Regeneron Pharmaceuticals, Inc.; and Topcon Healthcare, Inc.
Activity Description
Diagnostic, therapeutic, and surgical modalities for the management of patients with retinal diseases continue to evolve, providing the potential to enhance visual and anatomic outcomes of these patients while enhancing quality-of-life measures. With a rapidly evolving armamentarium, it can be challenging to stay abreast of the latest advances, which could delay their optimal incorporation into clinical practice. This engaging gaming activity—designed for retina fellows, ophthalmology residents, and other healthcare professionals involved in the management of patients with retinal diseases—tests your knowledge of evidence-based approaches for the diagnosis, treatment, and management of diabetic macular edema, diabetic retinopathy, and neovascular age-related macular degeneration.
This program is Part 3 of a 3-part series for the Retina Summit 2025 entitled Retinal Diseases – A Wheel of Knowledge Challenge!. We invite you to also check out Part 1: DME/DR and nAMD: State-of-the-Art Management and Part 2: RVO, Imaging, Surgery, Dry AMD, and GA: State-of-the-Art Management.
Target Audience
The intended audience for this activity is ophthalmologists, ophthalmology residents, and retina fellows involved in the management of patients with retinal diseases.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Identify diagnostic and imaging modalities that improve early detection and disease monitoring.
- Describe evidence-based medicine and treatment algorithms for optimizing medical management of retinal diseases.
- Assess surgical advancements, procedures, and technologies that enhance surgical outcomes for retinal disorders.
- Summarize patient-centered and practice management strategies that improve overall care and patient outcomes.
- Discuss clinical experiences and emerging research with expert retina specialists.
Activity Chair
Rishi P. Singh, MD, FASRS
Chair of Ophthalmology
Mass Eye and Ear Infirmary, Mass General Brigham
Boston, MA
Faculty
Thomas A. Albini, MD
Professor of Clinical Ophthalmology
Bascom Palmer Eye Institute at Miami
Miami, FL
Vaidehi S. Dedania, MD
NYU Langone Health
NYU Grossman School of Medicine
Associate Professor of Ophthalmology
Director, Vitreoretinal Surgery Fellowship
New York, NY
Nimesh A. Patel, MD, FASRS, FAAP
Director of Pediatric Retina
Mass Eye and Ear and Mass General Hospital
Director of Pediatric Retina Surgery, Boston Children's Hospital
Assistant Professor of Ophthalmology
Harvard Medical School
Boston, MA
Jeremy D. Wolfe, MD, MS, FASRS
Co-President & Assistant Fellowship Director
Associated Retinal Consultants
Associate Professor of Ophthalmology
Oakland University William Beaumont School of Medicine
Royal Oak, MI
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, December 1, 2025, to November 30, 2026.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application. US Physicians who opt-in by providing their medical license number, state of licensure, and date of birth will have their credits automatically reported to the ACCME.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Thomas A. Albini, MD
Consultant: Adverum, Allergan, Bausch + Lomb, BVI, Clearside, EyePoint, Genentech, Neurotech, Novartis, Regenxbio
Vaidehi S. Dedania, MD
Consultant: 4DMT, AbbVie, Astellas, EyePoint, ONL Therapeutics
Nimesh A. Patel, MD, FASRS, FAAP
Advisor: Alcon, Alimera, Allergan, Apellis, Biogen, DORC, EyePoint, Genentech, Kyoto, Regeneron, Regenxbio, YoungMD Connect
Rishi P. Singh, MD
Consultant: Alcon, Apellis, Bausch + Lomb, EyePoint, Genentech, IVERIC bio, Regenxbio, Regeneron, Zeiss
Independent Research Contractor: Janssen
Jeremy D. Wolfe, MD, MS
Consultant: Alcon, Apellis, Genentech, Regeneron, Roche
Speaker Contracted by Ineligible Company: Apellis, Genentech
*Individual Stocks (privately held): Aviceda, Retinova, Vortex Surgical
*Will not discuss business line or products of the company(ies).
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2025 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com